JNJ · NYSE

JOHNSON & JOHNSON

Pharmaceutical Preparations

Listing type has not been classified. Company financial ratios are not specific to a share class. CIK 0000200406

Dividend overview

Latest reported dividend

$1.34

USD per share · regular

Payment date: Sep 8, 2026. This is not a forecast of the next payment.

Next announced payment

Not available

No future payment is present in our collected records.

Ex-dividend date

Not reported

For the next collected payment. An unreported date is not inferred from the record date.

Announced dates and amounts may change. Verify current details with the issuer and your broker before acting.

Cash flow & dividend coverage

Cash payout ratio

Not available

Annual cash dividends ÷ net income.

FCF payout ratio

Not available

Annual cash dividends ÷ (operating cash flow − PP&E expenditures).

Company-level · annual period Not reported – Not reported. Metric date: Oct 21, 2026. Calculated: 2026-10-21T11:56:01.509Z (UTC).

A ratio may be unavailable because comparable annual inputs are missing, earnings or free cash flow are nonpositive, or the reporting period is too old. Missing is not zero.

Payout ratios describe historical financial results and do not guarantee future dividends. Read the calculation rules.

Cash-dividend numerator: Comparable basis not available. Total cash dividends may include more than the common-share distribution.

Dividend history

Reported dividends · amounts per share
Payment date	Stock	Amount	Ex-dividend	Record date	Type / status	Source
Sep 8, 2026Declared: Jul 15, 2026	JNJ	$1.34USD · as reported	Not reported	Aug 25, 2026	regularAnnounced schedule	SEC filingFiled: Jul 23, 2026
Jun 9, 2026Declared: Apr 14, 2026	JNJ	$1.34USD · as reported	Not reported	May 26, 2026	regularAnnounced schedule	SEC filingFiled: Jul 23, 2026
Mar 10, 2026Declared: Jan 2, 2026	JNJ	$1.30USD · as reported	Not reported	Feb 24, 2026	regularAnnounced schedule	SEC filingFiled: Apr 22, 2026
Dec 9, 2025Declared: Oct 14, 2025	JNJ	$1.30USD · as reported	Not reported	Nov 25, 2025	regularAnnounced schedule	SEC filingFiled: Oct 22, 2025
Sep 9, 2025Declared: Jul 16, 2025	JNJ	$1.30USD · as reported	Not reported	Aug 26, 2025	regularAnnounced schedule	SEC filingFiled: Oct 22, 2025
Jun 10, 2025Declared: Apr 15, 2025	JNJ	$1.30USD · as reported	Not reported	May 27, 2025	regularAnnounced schedule	SEC filingFiled: Jul 24, 2025
Mar 4, 2025Declared: Jan 2, 2025	JNJ	$1.24USD · as reported	Not reported	Feb 18, 2025	regularAnnounced schedule	SEC filingFiled: Apr 23, 2025
Dec 10, 2024Declared: Oct 15, 2024	JNJ	$1.24USD · as reported	Not reported	Nov 26, 2024	regularAnnounced schedule	SEC filingFiled: Oct 23, 2024
Sep 10, 2024Declared: Jul 17, 2024	JNJ	$1.24USD · as reported	Not reported	Aug 27, 2024	regularAnnounced schedule	SEC filingFiled: Oct 23, 2024
Jun 4, 2024Declared: Apr 16, 2024	JNJ	$1.24USD · as reported	Not reported	May 21, 2024	regularAnnounced schedule	SEC filingFiled: Jul 25, 2024

Announced dates and amounts may change. An elapsed payment date is not confirmation of payment. As-reported amounts may not be comparable across stock splits.

Financial context

Company financials →

Annual net income

Reported annual periods; USD. Negative values extend below the baseline.

Selected annual US-GAAP cash-flow and earnings facts · USD
Reporting period	Measure	USD millions	Filing
Dec 28, 2025From Dec 30, 2024	Operating cash flow	24,530.0	SEC filingFeb 11, 2026
Dec 28, 2025From Dec 30, 2024	Net income	26,804.0	SEC filingFeb 11, 2026
Dec 28, 2025From Dec 30, 2024	Capital expenditures (PP&E)	4,832.0	SEC filingFeb 11, 2026
Dec 29, 2024From Jan 1, 2024	Operating cash flow	24,266.0	SEC filingFeb 11, 2026
Dec 29, 2024From Jan 1, 2024	Net income	14,066.0	SEC filingFeb 11, 2026
Dec 29, 2024From Jan 1, 2024	Capital expenditures (PP&E)	4,424.0	SEC filingFeb 11, 2026
Dec 31, 2023From Jan 2, 2023	Operating cash flow	22,791.0	SEC filingFeb 11, 2026
Dec 31, 2023From Jan 2, 2023	Net income	35,153.0	SEC filingFeb 11, 2026
Dec 31, 2023From Jan 2, 2023	Capital expenditures (PP&E)	4,543.0	SEC filingFeb 11, 2026
Jan 1, 2023From Jan 3, 2022	Operating cash flow	21,194.0	SEC filingFeb 13, 2025
Jan 1, 2023From Jan 3, 2022	Net income	17,941.0	SEC filingFeb 13, 2025
Jan 1, 2023From Jan 3, 2022	Capital expenditures (PP&E)	4,009.0	SEC filingFeb 13, 2025
Jan 2, 2022From Jan 4, 2021	Operating cash flow	23,410.0	SEC filingFeb 16, 2024
Jan 2, 2022From Jan 4, 2021	Net income	20,878.0	SEC filingFeb 16, 2024
Jan 2, 2022From Jan 4, 2021	Capital expenditures (PP&E)	3,652.0	SEC filingFeb 16, 2024
Jan 3, 2021From Dec 30, 2019	Operating cash flow	23,536.0	SEC filingFeb 16, 2023
Jan 3, 2021From Dec 30, 2019	Net income	14,714.0	SEC filingFeb 16, 2023
Jan 3, 2021From Dec 30, 2019	Capital expenditures (PP&E)	3,347.0	SEC filingFeb 16, 2023
Dec 29, 2019From Dec 31, 2018	Operating cash flow	23,416.0	SEC filingFeb 17, 2022
Dec 29, 2019From Dec 31, 2018	Net income	15,119.0	SEC filingFeb 17, 2022

Latest filed value per tag and exact annual period, within the last seven years. Common-stock and total cash dividends are separate measures; do not add them together. These selected facts are not a complete financial statement.

Read the numbers in context

A higher payout ratio can reflect a larger dividend, lower earnings, or both. Capital spending also affects the FCF denominator. The accounting context matters, especially for financial firms, REITs, and business development companies.

Understand cash payout ratios · Regular vs. special dividends

Sources & corrections

Source: collected SEC filings. USYieldHub is not affiliated with or endorsed by the SEC or this issuer. Coverage is incomplete; amounts may be unadjusted for splits.

Data coverage · Report a data error · Compare this company